• Home
  • National News
  • Business & Economy
  • Technology
  • Humanities & Science
  • Health & Lifestyle
  • About
    • Our Team
    • Contact Us
    • Corrections
    • Privacy Policy GDPR
    • Terms of Use
  • Latest News
    • Jury Finds Meagan Grunwald Guilty in Sheriff Wride’s Death
    • Demon Hunters and PvP Perks in World of Warcraft
    • Wells Fargo Sacks Four Bankers amid Fresh Investigation
    • Alibaba Expanding Stake in Rapid-Growing Delivery Business
    • Bush’s top PAC aide steps down over sexist, racial remarks
    • Scientists Discover New Yeti Crab Family Species
    • The Cheyenne Mountain Complex Super Bunker Is as Real as North Korea’s Nukes
    • Bat Fossils Reveal The Colour Of Prehistoric Animals
    • Printers’ Unique System of Microdots Could Be Put to Good Use by the FBI
    • A Thief’s End Was Stolen
    • Petco not Guilty in Rat Bite Fever Case
    • Weakened Eyes Might Give Away Jane Austen’s Cause of Death
  • Home
  • National News
  • Business & Economy
  • Technology
  • Humanities & Science
  • Health & Lifestyle
  • About
    • Our Team
    • Contact Us
    • Corrections
    • Privacy Policy GDPR
    • Terms of Use
  • Latest News
    • Jury Finds Meagan Grunwald Guilty in Sheriff Wride’s Death
    • Demon Hunters and PvP Perks in World of Warcraft
    • Wells Fargo Sacks Four Bankers amid Fresh Investigation
    • Alibaba Expanding Stake in Rapid-Growing Delivery Business
    • Bush’s top PAC aide steps down over sexist, racial remarks
    • Scientists Discover New Yeti Crab Family Species
    • The Cheyenne Mountain Complex Super Bunker Is as Real as North Korea’s Nukes
    • Bat Fossils Reveal The Colour Of Prehistoric Animals
    • Printers’ Unique System of Microdots Could Be Put to Good Use by the FBI
    • A Thief’s End Was Stolen
    • Petco not Guilty in Rat Bite Fever Case
    • Weakened Eyes Might Give Away Jane Austen’s Cause of Death

America Herald

Tagged: Sanofi

Consumer Goods & Biopharma Sector · Health & Lifestyle

0

After FDA, Sanofi, Regeneron seek EMA approval for new cholesterol drug

  • January 12, 2015

Drug makers Sanofi and Regeneron have filed an application with the European Medicines Agency (EMA) seeking approval for their new drug alirocumab for lowering ‘bad’ cholesterol levels. The new cholesterol-lowering[…]

Consumer Goods & Biopharma Sector · Health & Lifestyle

0

Merck’s Cholesterol drug Zetia results boosts shares along with other pharma firms

  • November 19, 2014

Merck & Co. (MRK) shares surged 0.73 percent, nearly one percent, to USD 59.50 after a nearly decade long study proved the embattled drug Zetia effective in lowering heart attacks[…]

  • Subscribe to Blog via Email

    Enter your email address to subscribe to this blog and receive notifications of new posts by email.

    Join 23 other subscribers

  • Categories

    • Auto Industry & Manufacturing Sector
    • Company News & Financials
    • Consumer Goods & Biopharma Sector
    • Entertainment
    • Health
    • Health & Lifestyle
    • Humanities & Science
    • National News
    • Nature
    • Science
    • Technology
    • U.S.
    • Uncategorized
    • World

        Copyrights 2014 America Herald. All Rights Reserved